Greenskeeper
Our archive holds 8 letters from Greenskeeper, behind 9 investment theses and positions in 18 companies. Every quote below is copied verbatim from the letter it came from.
Get an email when this fund publishes its next letter
Performance
as of Sep 30, 2026 · net of fees · CAD · Class F
- YTD+1.0%
- 1Y+1.2%
- 3Y · /yr+10.1%
- 5Y · /yr+7.6%
- 10Y · /yr+9.1%
- Inception · /yr+9.1%
| YTD | 1Y | 3Yper year | 5Yper year | 10Yper year | Since inceptionper year | |
|---|---|---|---|---|---|---|
| GreensKeeper Value Fund | +1.0% | +1.2% | +10.1% | +7.6% | +9.1% | +9.1% |
These figures are copied from the manager’s latest letter, as of Sep 30, 2026. They were extracted automatically, have not been verified by HF Best Ideas and may contain errors. They cover a single share class, in the currency and fee basis stated above; other share classes and your own returns will differ. This is not investment advice, nor an offer to buy or sell any fund. Past performance does not predict future returns.
Read full disclosures →What they bought and sold · 4 moves
- ExitedLululemon AthleticaSeptember 2026
“Following its second-quarter earnings release, we exited our position in Lululemon Athletica (LULU).”
Read the letter - TrimmedMobility Global Inc.September 2026
“Shortly after quarter-end, we sold our small position in Mobility Global Inc. (MBGL), which we received following its spin-off from S&P Global (SPGI).”
Read the letter - ExitedNovo NordiskSeptember 2026
“Following its recent Capital Markets Day, we fully exited our position in Novo Nordisk (NVO).”
Read the letter - AddedICON plcJune 2026
“we decided to materially increase our position.”
Read the letter
Companies held · 18
Every company Greenskeeper has disclosed a position in across our archive, with the letter that last mentioned it.
- Alphabet Inc.Sep 2026
- American Express CompanySep 2026
- Automatic Bank Services LimitedSep 2026
- Berkshire Hathaway Inc.Sep 2026
- Berkshire Hathaway Inc.Jun 2026
- Compagnie Financière Richemont SASep 2026
- Elevance Health, Inc.Sep 2026
- ICON Public Limited CompanySep 2026
- Intercontinental ExchangeSep 2026
- Lockheed MartinJun 2026
- Lululemon AthleticaSep 2026
- MarketAxess Holdings Inc.Sep 2026
- Mobility Global Inc.Sep 2026
- Novo NordiskSep 2026
- QuebecorSep 2026
- S&P Global Inc.Sep 2026
- TVA GroupSep 2026
- Visa Inc.Sep 2026
Theses · 9
- September 2026
TVA Group is viewed as an undervalued broadcaster with a core turnaround, debt-free balance sheet, and hidden asset value from real estate and pension surplus.
Read the full thesis - September 2026
Intercontinental Exchange is seen as a resilient market infrastructure company with recurring-revenue moats and expansion into fixed-income trading through MarketAxess.
Read the full thesis - September 2026
Visa is positioned as an indispensable payments network that can co-opt stablecoin innovation and defend its global tollbooth moat.
Read the full thesis - Automatic Bank Services LimitedSeptember 2026
Automatic Bank Services Limited is viewed as a near-monopoly payment infrastructure operator with pricing power and margin recovery potential after mandated investments.
Read the full thesis - September 2026
Compagnie Financière Richemont is viewed as a high-quality luxury jeweller with strong pricing power, heritage brands, and long-term compounding potential.
Read the full thesis - June 2026
Intercontinental Exchange, Inc. has strong earnings growth, a defensible franchise in energy markets, and market-leading infrastructure that supports long-term compounding.
Read the full thesis - June 2026
Elevance Health, Inc. has a strong commercial health insurance franchise, improving cost trends, and potential for an earnings recovery.
Read the full thesis - June 2025
Novo Nordisk is a leading insulin maker whose growth is currently driven by its GLP-1 franchise, and despite competitive pressures, its pipeline remains undervalued in a growing market.
Read the full thesis - March 2025
Icon PLC (ICLR) is a leading contract research organization that will benefit from ongoing development of new drugs and medical devices, despite current regulatory uncertainties.
Read the full thesis
Letter archive · 8
2025
Get Greenskeeper’s next letter the day it lands
We track Greenskeeper alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.
View plans→